Glycomics / Glycobiology Market

Drug Discovery and Development, and Oncology Sgments are New Revenue Pockets for Players in the Glycomics Enzymes, Instruments, Kits and Reagents Market

The application segments of drug discovery and development, and oncology will be important revenue pockets of the glycomics market in the forecast period (2014 - 2019). The drug discovery and development applications segment is expected to grow at the highest CAGR between 2012 and 2019. Glycomics research will aid in the investigation of defective proteins and how they may cause particular diseases, which by extension helps in developing new drugs. Furthermore, glycomics products are used to identify new biomarkers for cancers; these biomarkers act as key diagnostic targets for various types of cancers. Biomarkers can also be used for devising novel and personalized therapies for diseases like cancer.

The incidence of cancer is increasingly rapidly across the globe. According to GLOBOCAN, about 14.1 million new cancer cases and 8.2 million cancer-related deaths were recorded globally in 2012. Based on GLOBOCAN’s statistics, the International Agency for Research on Cancer (ICRA) and the World Health Organization (WHO) estimated that by 2025, around 19.3 million new cancer cases may occur each year. The rising incidence of cancer has increased research interest and funding for oncology, which is expected to drive the growth of the oncology applications segment.

North America accounted for the largest share of the global glycomics market in 2014 and is expected to grow at the highest CAGR in the forecast period for this report (2012–2019). North America is expected to witness a steady year-on-year growth, owing to the trend of outsourcing drug discovery research activities to countries in this geography. Moreover, an increase in healthcare budgets and R&D activities in this region will further fuel the demand for products offered in the glycomics market.

Related Reports:

Glycobiology/Glycomics Market by Product [Enzymes (Glycosyltransferase, Neuraminidase, Glycosidase), Instruments (HPLC, Mass Spectrometry, MALDI-TOF), Kits, and Reagents], Application (Immunology, Oncology) & by End User - Global Forecast to 2019
https://www.marketsandmarkets.com/Market-Reports/glycobiology-market-132685525.html

Contact:
Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com

Report Code
BT 2776
RI Published ON
10/29/2014
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Glycomics / Glycobiology Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved